1. COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.
- Author
-
Alhouayek M and Muccioli GG
- Subjects
- Animals, Arachidonic Acids metabolism, Dinoprostone analogs & derivatives, Dinoprostone metabolism, Humans, Prostaglandins G metabolism, Cyclooxygenase 2 metabolism, Endocannabinoids metabolism, Endocannabinoids pharmacology, Inflammation Mediators metabolism, Inflammation Mediators pharmacology
- Abstract
Cyclooxygenase-2 (COX-2) is an enzyme that plays a key role in inflammatory processes. Classically, this enzyme is upregulated in inflammatory situations and is responsible for the generation of prostaglandins (PGs) from arachidonic acid (AA). One lesser-known property of COX-2 is its ability to metabolize the endocannabinoids, N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG). Endocannabinoid metabolism by COX-2 is not merely a means to terminate their actions. On the contrary, it generates PG analogs, namely PG-glycerol esters (PG-G) for 2-AG and PG-ethanolamides (PG-EA or prostamides) for AEA. Although the formation of these COX-2-derived metabolites of the endocannabinoids has been known for a while, their biological effects remain to be fully elucidated. Recently, several studies have focused on the role of these PG-G or PG-EA in vivo. In this review we take a closer look at the literature concerning these novel bioactive lipids and their role in inflammation., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF